Anzeige
Mehr »
Login
Dienstag, 07.12.2021 Börsentäglich über 12.000 News von 681 internationalen Medien
Wachgeküsst! Vom „Diesel-Entlein“ zum „Elektro-Schwan“!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JKVH ISIN: IE00B56GVS15 Ticker-Symbol: 8AK 
Stuttgart
07.12.21
08:01 Uhr
19,600 Euro
+0,100
+0,51 %
1-Jahres-Chart
ALKERMES PLC Chart 1 Jahr
5-Tage-Chart
ALKERMES PLC 5-Tage-Chart
RealtimeGeldBriefZeit
19,70020,00012:21
19,80020,00011:50

Aktuelle News zur ALKERMES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
24.11.Alkermes plc: Alkermes to Take Part in the Fourth Annual Evercore ISI HealthCONx Conference467DUBLIN, Nov. 24, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the fourth annual Evercore ISI HealthCONx Conference...
► Artikel lesen
19.11.Alkermes plc. - 8-K, Current Report2
19.11.Alkermes plc: Alkermes Announces the Appointment of Cato T. Laurencin, M.D., Ph.D. to its Board of Directors303DUBLIN, Nov. 19, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Cato T. Laurencin, M.D., Ph.D., to the company's Board of...
► Artikel lesen
ALKERMES Aktie jetzt für 0€ handeln
11.11.Alkermes plc: Alkermes Announces First Subject Dosed in Phase 1 Study of ALKS 1140 for the Treatment of Neurodegenerative and Neurological Disorders337DUBLIN, Nov. 11, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced dosing of the first subject in a phase 1 study evaluating the safety and tolerability of ALKS 1140 in healthy...
► Artikel lesen
09.11.Alkermes plc: Alkermes to Take Part in the Stifel Virtual Healthcare Conference176DUBLIN, Nov. 9, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Stifel Virtual Healthcare Conference on Tuesday...
► Artikel lesen
09.11.Why Alkermes Stock Is Sinking Today8
09.11.J&J tries to back out of nanoparticle license agreement - but Alkermes says 'not so fast'7
08.11.Alkermes slips as Johnson & Johnson moves to end licensing pact10
08.11.Alkermes plc: Alkermes Announces Receipt of Notices of Partial Termination From Janssen Pharmaceutica307- Investor Conference Call Scheduled for Today at 5:00 p.m. ET DUBLIN, Nov. 8, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it received notices of partial termination...
► Artikel lesen
03.11.Alkermes plc: Alkermes to Present Data on Nemvaleukin Alfa at the Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting185DUBLIN, Nov. 3, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present a poster related to nemvaleukin alfa (nemvaleukin), the company's novel, investigational...
► Artikel lesen
29.10.Alkermes plc: Alkermes to Present New Research From Psychiatry and Addiction Portfolios at Upcoming Scientific Conferences200-- Clinical Data, Epidemiology and Health Economics and Outcomes Research to be Shared at Psych Congress, ISAD Conference and NEI Congress -- DUBLIN, Oct. 29, 2021 /PRNewswire/ -- Alkermes...
► Artikel lesen
28.10.Alkermes plc 2021 Q3 - Results - Earnings Call Presentation2
28.10.Alkermes (ALKS) Q3 Earnings Beat Estimates, Revenues Miss-
27.10.Alkermes plc. (ALKS) CEO Richard Pops on Q3 2021 Results - Earnings Call Transcript1
27.10.Why Are Alkermes Shares Trading Lower Today?3
27.10.Alkermes shares slide after Q3 topline miss2
27.10.Alkermes plc. - 10-Q, Quaterly Report3
27.10.Alkermes plc Q3 adjusted earnings Beat Estimates135WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alkermes plc (ALKS):-Earnings: -$28.99 million in Q3 vs. -$0.13 million in the same period last year. -EPS: -$0.18 in Q3 vs. $0.00...
► Artikel lesen
27.10.Alkermes EPS beats by $0.04, misses on revenue6
27.10.Alkermes plc. - 8-K, Current Report1
Seite:  Weiter >>
93 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1